p38 MAP Kinase Inhibitors as Potential Therapeutic Drugs for Neural Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1875-6166|11|1|45-59

ISSN： 1871-5249

Source： Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol.11, Iss.1, 2011-03, pp. : 45-59

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases

By Chopra Puneet   Kanoje Vijay   Semwal Arvind   Ray Abhijit  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 10, 2008-10 ,pp. : 1411-1425

Informa Healthcare

Access to resources Recommend Favorite

Pyridinylimidazole Based p38 MAP Kinase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 9, 2002-09 ,pp. : 1011-1020

Bentham Science Publishers

Access to resources Recommend Favorite

Small Molecule p38 MAP Kinase Inhibitors for the Treatment of Inflammatory Diseases: Novel Structures and Developments During 2006- 2008

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 16, 2008-11 ,pp. : 1452-1467

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Rho-Kinase Inhibitors in Cardiovascular Diseases

By Hirooka Yoshitaka   Shimokawa Hiroaki  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 1, 2005-01 ,pp. : 31-39

Adis International

Access to resources Recommend Favorite

The Non-Diaryl Heterocycle Classes of p38 MAP Kinase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 9, 2002-09 ,pp. : 1021-1035

Bentham Science Publishers

Access to resources Recommend Favorite